MedTrace Logo

Ibuprofen-PC Compared With Ibuprofen in a GI Safety Trial

NCT00219700 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 125

Last updated 2008-11-26

No results posted yet for this study

Summary

To determine the safety and efficacy of 3 x 800 mg/day IBU-PC assessed by endoscopy and incidence of adverse events

Conditions

Interventions

DRUG

Ibuprofen-PC

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Texas Higher Education Coordinating Board

    collaborator OTHER_GOV

  • PLx Pharma

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2005-11-30
Completion
2005-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00219700 on ClinicalTrials.gov